Our Unique Focus
Our Unique Focus
Our Unique Focus
Eliomedica Inc is a strategy firm with a focus on medical devices. We specialize in crafting comprehensive market entry strategies, aligning regulatory, development, and business milestones.
Our holistic strategy approach reduces time to market and development costs, ensuring your product creates value, attracts investment, and achieves commercial success.
Where We Shine
Our Unique Focus
Our Unique Focus
Our team blends regulatory, science, and commercialization expertise, excelling in software, hardware, and connected devices, including:
- Point-of-Care & Cloud-Connected Devices
- Electro-Mechanical Systems
- Software-as-a-Medical Device (SaMD)
- Digital Health
We are technology enabled, leveraging Nyquist AI global intelligence platform with clinical, regulatory and medical device data.
What We Offer
Our Unique Focus
What We Offer
We are a small team with reputable partners in Toronto and California. Our engagement model provides tailored partnerships, hands on delivery and continuous support toward a successful market entry.
We are dedicated to partnering with startups, spin-offs from large organizations, and physician entrepreneurs. Tailored to your startup stage, our engagement model can be project-based, retainer, equity, outcome-based, or a combination.
Regulatory Affairs
Product-Market Fit Strategy
Product-Market Fit Strategy
- Strategy and roadmapping
- Pre-submissions and submissions
- FDA communications
- Design History Files (DHF)
Product-Market Fit Strategy
Product-Market Fit Strategy
Product-Market Fit Strategy
- Market landscape analysis
- Value proposition development
- Validation and sales strategy
- Reimbursement strategy
Research & Development
Product-Market Fit Strategy
Research & Development
- Concept studies
- Scientific and technical evaluation
- Pre-clinical and clinical strategies
- Usability studies
Systems Engineering
Systems Engineering
Research & Development
- Requirements & risks management
- Verification & validation strategy
- Design controls & traceability
Investor Relations
Systems Engineering
Investor Relations
- Funding strategy & pitch dev
- Introductions & communications
- Due diligence & negotiation
Roadmapping
Systems Engineering
Investor Relations
- Concept to launch
- Go-to-market
- Cross-functional alignment
Converging Regulatory, Science and Strategy
We are a small team with well-respected and reputable partners in Toronto and California. We are responsive, personalized, and committed to providing tailored solutions that meet the unique needs of each client. Unlike larger consulting firms, our size allows us to offer a more intimate and hands-on approach, ensuring that every project receives the dedicated attention it deserves. By working with us, you benefit from direct access to our experienced professionals and a flexible, adaptive service model that can quickly pivot to address emerging challenges and opportunities.
Arash Samimi, PhD
Parth Agarwal, MBA
Parth Agarwal, MBA
Founder & Managing Partner
Market Entry Strategy
Highlights:
Ecosystem Partner, EEE Corp Group
Business Dev, StarFish Medical
Systems Eng, Synaptive Medical
Parth Agarwal, MBA
Parth Agarwal, MBA
Parth Agarwal, MBA
Partner
Sales & Go-to-Market Strategy
Highlights:
Business Dev & Investor, MediPines
Business Dev & investor, Pramptex
Golnaz Moeini, RAC
Parth Agarwal, MBA
Golnaz Moeini, RAC
Sr Consultant
Regulatory Strategy
Highlights:
Founder, MedEdge Regulatory
Director at Arterys, RA at Stryker
Emily Hayhurst
Parth Agarwal, MBA
Golnaz Moeini, RAC
Consultant
Design & Communications Strategy
Highlights:
Human Factors Eng, StarFish Medical
Design Researcher, SleepLabs
T. David Pyron
Francis Jeanson, PhD
Francis Jeanson, PhD
Sr Consultant
Product Development Strategy
Highlights:
Program Mgr, StarFish Medical
Director, Seaspan
Francis Jeanson, PhD
Francis Jeanson, PhD
Francis Jeanson, PhD
Advisor
Health Data & AI Strategy
Highlights:
Head, Ontario Brain Institute
Director, UHN
Golddy Kaur
Francis Jeanson, PhD
Golddy Kaur
Advisor
Regulatory & Business Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
Through the Eyes of our Clients
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
Dr. Anya McLaren-Barnett
Founder, The Sleep Health Organization
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
CEO, Deep Breathe AI
Our Community Partners
